‘Significant shortage’ of Mo-99 expected in November

Subrata Thakar | | Radiology Business | Practice Management

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced a “significant shortage” of molybdenum-99 (Mo-99) during the first half of November due to operations issues at various facilities.

“The NTP facility in South Africa, which has experienced problems since late last year, has not yet been able to return to service,” read a statement issued by SNMMI. “The NTP shutdown coincides with a planned 11-day shutdown of the OPAL reactor in Australia that began October 29, so significant shortages of Mo-99 are anticipated starting in early November.”

The SNMMI noted users should contact their generator or nuclear pharmacy providers to assess the local impact of the shortage.

 

""
Subrata Thakar

As a senior news writer for TriMed, Subrata covers cardiology, clinical innovation and healthcare business. She has a master’s degree in communication management and 12 years of experience in journalism and public relations.

Related Content

US Radiology Specialists affiliate expands into new market
Navigating the radiology workforce shortage: 6 potential solutions
Radiologist rails against insurer’s refusal to cover key interventional service
Blue Cross Blue Shield affiliate rejects MRI contrast coverage, labeling it ‘investigational’
Radiology experts say state Medicaid rates must increase to improve imaging access
Can large language models break language barriers in radiology reports?

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.